Lei Yee et al. highlight benefits of harm reduction interventions to reduce injecting-related harms whilst describing barriers in relation to availability, cost and privacy.
Palmateer et al. confirm the value of key harm reduction interventions to reduce HCV and HIV transmission, and identify remaining gaps in the evidence base for a range of health interventions.
Neale et al. highlight diversity of experiences and need to offer a broad range of interventions, including pharmacotherapy, psychosocial support and safe spaces.
Barrett et al. propose a conceptual framework to encompass the theoretical, practical, ethical and legal issues pertaining to a harm reduction approach for minors.
This technical brief sets out guiding principles and targeted interventions to reduce the risk of HIV transmission and facilitate access to healthcare for transgender people deprived of liberty.
The NZ Drug Foundation and Helen Clark Foundation discuss use patterns and markets in Aotearoa / New Zealand, related harms, current regulations and how to reduce harms through psychosocial, cultural, and pharmacological approaches.
The CESeC presents data on the costs of drug prohibition for seven institutions of the criminal justice systems of the states of Rio de Janeiro and São Paulo.
